Linking Profile To Preference-Based Measures - Don't Regress

Published Mar 31, 2014
Aberdeen, UK & Los Angeles, CA, USA - Health-related quality of life measures can provide useful information to decision makers involved in health care resource allocation.  These decision makers are concerned with the planning of health care services and are often interested in how they can most efficiently use the resources available to them.  Many health-related quality of life measures provide multiple scores (“profiles”) but decision makers need a single preference-based score for economic evaluation.  Methods exist for estimating preference-based scores from profile measures to support cost effectiveness analysis.  In the UK, the National Institute for Health and Care Excellence (NICE) has produced guidelines for how to undertake such mapping approaches. Regression models are frequently used in which health-related quality of life profile scores are used to predict a single index preference score.  In the study, “Should Linking Replace Regression When Mapping from Profile-Based Measures to Preference-Based Measures?” researchers from the Norwegian University of Science and Technology and the University of California at Los Angeles, noted that one particular problem with existing statistical approaches is the fact that “true” scores are actually closer to the mean than observed scores because of random variation (regression to the mean). The researchers then proposed an alternative approach to establishing mapping functions that avoids this problem.  A non-parametric variant of linear scale-aligning was proposed to ensure that the predicted scores are the same number of standard deviations above or below the mean as the predictor variable (x-scores). Dr. Peter Fayers, PhD, from the Institute of Applied Health Sciences at the University of Aberdeen, UK, and lead author on the study states, “We recommend the use of parametric linking functions or equipercentile methods to estimate preference-based scores from profile measures. These alternatives avoid the problems of existing methods and offer us a whole new way to address gaps in the evidence base for decision makers.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision-makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Follow Value in Health on Twitter: @ISPORJournals

For more information: www.ispor.org

Related Stories

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

New Research Reveals Surprising Trends in Women's Health Economics Authorship

May 12, 2025

Value in Health, the official journal of ISPOR announced the publication of new research analyzing women's representation in authorship of papers submitted to and published in Value in Health. The report, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×